Taniuchi et al. [15] demonstrated that the combination of PODXL with ITGB1 and that of BCL7B with ITGB1 accurately predicted the postoperative outcomes of pancreatic cancer patients; these predictors were superior compared to the TNM staging system. This evidence concerns the gene ITGB1 and pancreatic neoplasm.